Envision Healthcare (EVHC) Given a $46.00 Price Target at Jefferies Group

Envision Healthcare (NYSE:EVHC) received a $46.00 target price from equities research analysts at Jefferies Group in a research report issued on Wednesday. The brokerage presently has a “buy” rating on the stock. Jefferies Group’s price objective points to a potential upside of 27.96% from the company’s previous close.

Several other brokerages have also recently issued reports on EVHC. Robert W. Baird reissued a “buy” rating and issued a $70.00 target price on shares of Envision Healthcare in a research report on Tuesday, October 17th. Oppenheimer lowered their price objective on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating on the stock in a research report on Thursday, November 2nd. Cantor Fitzgerald cut Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 price objective on the stock. in a research report on Wednesday, November 1st. Stephens reaffirmed a “hold” rating and set a $34.00 price objective on shares of Envision Healthcare in a research report on Wednesday, January 10th. Finally, Bank of America cut Envision Healthcare from a “buy” rating to a “neutral” rating and set a $32.00 price objective on the stock. in a research report on Thursday, November 2nd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company’s stock. Envision Healthcare has a consensus rating of “Hold” and a consensus target price of $41.83.

Shares of Envision Healthcare (NYSE EVHC) traded up $1.13 during trading hours on Wednesday, reaching $35.95. The company’s stock had a trading volume of 304,698 shares, compared to its average volume of 2,167,452. The stock has a market capitalization of $4,194.86, a PE ratio of -7.20, a price-to-earnings-growth ratio of 0.90 and a beta of 0.58. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $73.00.

Several hedge funds have recently bought and sold shares of EVHC. CIBC World Markets Inc. bought a new stake in Envision Healthcare during the 4th quarter valued at approximately $208,000. Palisade Capital Management LLC NJ bought a new stake in Envision Healthcare during the 3rd quarter valued at approximately $229,000. CENTRAL TRUST Co raised its stake in Envision Healthcare by 79.7% during the 4th quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock valued at $229,000 after purchasing an additional 2,939 shares during the period. Alps Advisors Inc. bought a new stake in Envision Healthcare during the 4th quarter valued at approximately $235,000. Finally, M&T Bank Corp raised its stake in Envision Healthcare by 33.6% during the 4th quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock valued at $235,000 after purchasing an additional 1,716 shares during the period.

TRADEMARK VIOLATION WARNING: This article was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.com-unik.info/2018/02/08/envision-healthcare-evhc-given-a-46-00-price-target-at-jefferies-group.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit